BNP Paribas Financial Markets’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6M | Buy |
165,667
+23,043
| +16% | +$3.98M | 0.02% | 648 |
|
|
2025
Q1 | $22.2M | Buy |
142,624
+42,601
| +43% | +$6.64M | 0.01% | 725 |
|
|
2024
Q4 | $13.8M | Sell |
100,023
-78,682
| -44% | -$10.8M | 0.01% | 832 |
|
|
2024
Q3 | $26.7M | Buy |
178,705
+50,631
| +40% | +$7.56M | 0.02% | 527 |
|
|
2024
Q2 | $17.5M | Buy |
128,074
+52,534
| +70% | +$7.16M | 0.01% | 602 |
|
|
2024
Q1 | $11.4M | Buy |
75,540
+73,796
| +4,231% | +$11.2M | 0.01% | 733 |
|
|
2023
Q4 | $220K | Buy |
1,744
+999
| +134% | +$126K | ﹤0.01% | 2466 |
|
|
2023
Q3 | $69.8K | Sell |
745
-203
| -21% | -$19K | ﹤0.01% | 2727 |
|
|
2023
Q2 | $84.6K | Sell |
948
-17
| -2% | -$1.52K | ﹤0.01% | 2688 |
|
|
2023
Q1 | $103K | Buy |
965
+603
| +167% | +$64.7K | ﹤0.01% | 2693 |
|
|
2022
Q4 | $44.2K | Sell |
362
-438
| -55% | -$53.5K | ﹤0.01% | 2786 |
|
|
2022
Q3 | $82.6K | Buy |
800
+75
| +10% | +$7.75K | ﹤0.01% | 3135 |
|
|
2022
Q2 | $67.4K | Buy |
+725
| New | +$67.4K | ﹤0.01% | 2848 |
|
|
2022
Q1 | – | Sell |
-11,191
| Closed | -$1.51M | – | 3574 |
|
|
2021
Q4 | $1.51M | Buy |
+11,191
| New | +$1.51M | ﹤0.01% | 1750 |
|
|
2020
Q2 | – | Sell |
-12,100
| Closed | -$1.36M | – | 3680 |
|
|
2020
Q1 | $1.36M | Buy |
+12,100
| New | +$1.36M | ﹤0.01% | 1252 |
|